The long half-life and slow absorption and elimination rates mean it lingers in your system, so you don't need more frequent doses to keep it around and effective
10.1016/j.ahj.2011.09.012 Am Heart J
A 2024 study examining weight loss plateaus observed that, for subjects taking semaglutide, weight loss began to plateau after 15 months
A study from Oxford University covering over 100 million patient records found that Ozempic users showed 28% less risk of cognitive problems compared to people taking other diabetes medications
Wegovy, Ozempic: The barriers to accessing these weight loss drugs 'Starting Wegovy means staying on Wegovy' long-term, one doctor said There are a handful of barriers that may prevent patients from being able to attain highly sought-after drugs Wegovy and Ozempic including elevated cost, lack of insurance coverage and availability
Sources Lovelace, B., Jr., McLaughlin, E., & Heikkila, A